Ratings for Procter & Gamble PG were provided by 13 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 4 | 6 | 3 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 2 | 1 | 0 | 0 |
2M Ago | 3 | 3 | 2 | 0 | 0 |
3M Ago | 0 | 1 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $177.85, a high estimate of $190.00, and a low estimate of $161.00. This current average reflects an increase of 3.64% from the previous average price target of $171.60.
Diving into Analyst Ratings: An In-Depth Exploration
In examining recent analyst actions, we gain insights into how financial experts perceive Procter & Gamble. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Michael Pohn | DZ Bank | Announces | Buy | $190.00 | - |
Lauren Lieberman | Barclays | Lowers | Overweight | $163.00 | $174.00 |
Andrea Teixeira | JP Morgan | Lowers | Overweight | $179.00 | $181.00 |
Nik Modi | RBC Capital | Raises | Sector Perform | $164.00 | $157.00 |
Kaumil Gajrawala | Jefferies | Lowers | Hold | $175.00 | $182.00 |
Robert Moskow | TD Cowen | Announces | Buy | $189.00 | - |
Andrea Teixeira | JP Morgan | Raises | Overweight | $181.00 | $170.00 |
Mark Astrachan | Stifel | Raises | Hold | $161.00 | $157.00 |
Lauren Lieberman | Barclays | Raises | Overweight | $174.00 | $170.00 |
Robert Ottenstein | Evercore ISI Group | Raises | Outperform | $183.00 | $177.00 |
Steve Powers | Deutsche Bank | Raises | Buy | $176.00 | $171.00 |
Filippo Falorni | Citigroup | Raises | Buy | $190.00 | $177.00 |
Kevin Grundy | Exane BNP Paribas | Announces | Outperform | $187.00 | - |
Key Insights:
- Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Procter & Gamble. This insight gives a snapshot of analysts' perspectives on the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Procter & Gamble compared to the broader market.
- Price Targets: Understanding forecasts, analysts offer estimates for Procter & Gamble's future value. Examining the current and prior targets provides insight into analysts' changing expectations.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Procter & Gamble's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Procter & Gamble analyst ratings.
All You Need to Know About Procter & Gamble
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
Procter & Gamble: Delving into Financials
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Challenges: Procter & Gamble's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.1%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Staples sector.
Net Margin: Procter & Gamble's net margin excels beyond industry benchmarks, reaching 14.91%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Procter & Gamble's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 6.2%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.53%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.67, Procter & Gamble adopts a prudent financial strategy, indicating a balanced approach to debt management.
How Are Analyst Ratings Determined?
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.